‘Revolution’ in prostate cancer care as off-label breast cancer drug doubles survival
This article was taken from: https://www.telegraph.co.uk/science/2019/09/30/revolution-prostate-cancer-care-off-label-breast-cancer-drug/ By Henry Bodkin, health correspondent Abreast cancer drug has been used to double the survival of men with advanced prostate cancer, becoming the first successful precision medicine for the disease. Doctors at the Royal Marsden Hospital who conducted the trial say the results amount to a “revolution” in prostate cancer care. They…